Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Globus Medical stock

Own Globus Medical stock in just a few minutes.

Globus Medical, Inc is a medical devices business based in the US. Globus Medical shares (GMED) are listed on the NYSE and all prices are listed in US Dollars. Globus Medical employs 2,200 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Globus Medical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GMED – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Globus Medical share price

Use our graph to track the performance of GMED stocks over time.

Globus Medical shares at a glance

Information last updated 2021-04-30.
52-week range$42.85 - $72.82
50-day moving average $65.10
200-day moving average $61.90
Wall St. target price$71.47
PE ratio 71.7921
Dividend yield N/A (0%)
Earnings per share (TTM) $1.01

Buy Globus Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Globus Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Globus Medical under- or over-valued?

Valuing Globus Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Globus Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Globus Medical's P/E ratio

Globus Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 72x. In other words, Globus Medical shares trade at around 72x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Globus Medical's PEG ratio

Globus Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3465. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Globus Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Globus Medical's EBITDA

Globus Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $178.3 million.

The EBITDA is a measure of a Globus Medical's overall financial performance and is widely used to measure a its profitability.

Globus Medical financials

Revenue TTM $789 million
Operating margin TTM 14.63%
Gross profit TTM $571.6 million
Return on assets TTM 4.49%
Return on equity TTM 7.03%
Profit margin 12.96%
Book value $15.11
Market capitalisation $7.3 billion

TTM: trailing 12 months

Shorting Globus Medical shares

There are currently 1.5 million Globus Medical shares held short by investors – that's known as Globus Medical's "short interest". This figure is 26.8% up from 1.2 million last month.

There are a few different ways that this level of interest in shorting Globus Medical shares can be evaluated.

Globus Medical's "short interest ratio" (SIR)

Globus Medical's "short interest ratio" (SIR) is the quantity of Globus Medical shares currently shorted divided by the average quantity of Globus Medical shares traded daily (recently around 479022.25705329). Globus Medical's SIR currently stands at 3.19. In other words for every 100,000 Globus Medical shares traded daily on the market, roughly 3190 shares are currently held short.

However Globus Medical's short interest can also be evaluated against the total number of Globus Medical shares, or, against the total number of tradable Globus Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Globus Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Globus Medical shares in existence, roughly 20 shares are currently held short) or 0.0199% of the tradable shares (for every 100,000 tradable Globus Medical shares, roughly 20 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Globus Medical.

Find out more about how you can short Globus Medical stock.

Globus Medical share dividends

We're not expecting Globus Medical to pay a dividend over the next 12 months.

Globus Medical share price volatility

Over the last 12 months, Globus Medical's shares have ranged in value from as little as $42.85 up to $72.82. A popular way to gauge a stock's volatility is its "beta".

GMED.US volatility(beta: 1.02)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Globus Medical's is 1.0204. This would suggest that Globus Medical's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Globus Medical overview

Globus Medical, Inc. , a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Its offers spine products, such as consists of traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies, such as dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products, comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue based products; and COALITION, COALITION MIS, COALITION AGX, MONUMENT, MAGNIFY-S, HEDRON IATM, HEDRON ICTM, INDEPENDENCE, INDEPENDENCE MIS, FORTIFY and XPAND families, SABLETM, RISE, RISE INTRALIF, RISE-L, ELSA, ELSA ATP, RASS, ALTERA, ARIEL, LATIS, CALIBER and CALIBER-L products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site